Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ELOVL2 anticorps (AA 247-296)

Cet anticorps anti-ELOVL2 est un anticorps Lapin Polyclonal détectant ELOVL2 dans WB. Adapté pour Humain.
N° du produit ABIN7266927

Aperçu rapide pour ELOVL2 anticorps (AA 247-296) (ABIN7266927)

Antigène

Voir toutes ELOVL2 Anticorps
ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))

Reactivité

  • 20
  • 16
  • 1
Humain

Hôte

  • 35
Lapin

Clonalité

  • 35
Polyclonal

Conjugué

  • 11
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp ELOVL2 est non-conjugé

Application

  • 27
  • 19
  • 13
  • 13
  • 13
  • 11
  • 6
  • 3
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 15
    • 8
    • 5
    • 5
    • 3
    • 1
    • 1
    AA 247-296

    Fonction

    ELOVL2 Rabbit pAb

    Séquence

    ILFLNFYVQT YRKKPMKKDM QEPPAGKEVK NGFSKAYFTA ANGVMNKKAQ

     Réactivité croisée

    Humain, Rat

    Attributs du produit

    Polyclonal Antibodies

    Purification

    Affinity purification

    Immunogène

    Recombinant fusion protein containing a sequence corresponding to amino acids 247-296 of human ELOVL2 (NP_060240.3).

    Isotype

    IgG
  • Indications d'application

    WB,1:500 - 1:2000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène

    ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))

    Autre désignation

    ELOVL2

    Sujet

    Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs per cycle. Condensing enzyme that catalyzes the synthesis of polyunsaturated very long chain fatty acid (C20- and C22-PUFA, acting specifically toward polyunsaturated acyl-CoA with the higher activity toward C20:4(n-6 acyl-CoA. May participate in the production of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators.,SSC2,ELOVL2,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Endocrine and metabolic diseases,Diabetes,Cardiovascular,Heart,Lipids,Fatty Acids,Cardiovascular diseases,Heart disease,ELOVL2

    ID gène

    54898

    UniProt

    Q9NXB9
Vous êtes ici:
Chat with us!